A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Thriving Trade on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.
Several professionals stated the demand for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, advertising, and customer regulations, risking penalties, legal action or prison.
Service Response and Content Removal
According to the social media company, the platform has removed problematic material and banned related hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, glowing testimonials and detailed instructions for preparing or administering at residence.
After minutes of entering one community, a seller posted WhatsApp details, where the majority of purchases occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.
Item Details and Pricing
Inside these communities, posts show black plastic parcels with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they can’t verify. Although the science behind retatrutide is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to possibly serious health risks”.
